相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
Holly LaDuca et al.
GENETICS IN MEDICINE (2020)
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
Steven N. Hart et al.
GENETICS IN MEDICINE (2019)
A quantitative model to predict pathogenicity of missense variants in the TP53 gene
Cristina Fortuno et al.
HUMAN MUTATION (2019)
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T. Parsons et al.
HUMAN MUTATION (2019)
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Sean V. Tavtigian et al.
GENETICS IN MEDICINE (2018)
Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants
Cristina Fortuno et al.
HUMAN MUTATION (2018)
Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study
Esther M. John et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Allison W. Kurian et al.
JAMA ONCOLOGY (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
Melissa S. Cline et al.
PLOS GENETICS (2018)
Quality of Clinician-Reported Cancer History When Ordering Genetic Testing
Holly LaDuca et al.
JCO CLINICAL CANCER INFORMATICS (2018)
Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families
Belinda Vicuna et al.
JOURNAL OF COMMUNITY GENETICS (2018)
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
Miguel de la Hoya et al.
HUMAN MOLECULAR GENETICS (2016)
Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants
Maxime P. Vallee et al.
HUMAN MUTATION (2016)
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations
Barbara Alemar et al.
CANCER GENETICS (2016)
Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance
Nicholas T. Woods et al.
NPJ GENOMIC MEDICINE (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes
Dmitry Pruss et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ENIGMA-Evidence-Based Network for the Interpretation of Germline Mutant Alleles: An International Initiative to Evaluate Risk and Clinical Significance Associated with Sequence Variation in BRCA1 and BRCA2 Genes
Amanda B. Spurdle et al.
HUMAN MUTATION (2012)
A Review of a Multifactorial Probability-Based Model for Classification of BRCA1 and BRCA2 Variants of Uncertain Significance (VUS)
Noralane M. Lindor et al.
HUMAN MUTATION (2012)
Guidelines for Splicing Analysis in Molecular Diagnosis Derived from a Set of 327 Combined In Silico/In Vitro Studies on BRCA1 and BRCA2 Variants
Claude Houdayer et al.
HUMAN MUTATION (2012)
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
S. M. Edwards et al.
BRITISH JOURNAL OF CANCER (2010)
Classification of Rare Missense Substitutions, Using Risk Surfaces, With Genetic- and Molecular-Epidemiology Applications
Sean V. Tavtigian et al.
HUMAN MUTATION (2008)
Assessment of Functional Effects of Unclassified Genetic Variants
Fergus J. Couch et al.
HUMAN MUTATION (2008)
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes
Douglas F. Easton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Integrated evaluation of DNA sequence variants of unknown clinical significance:: Application to BRCA1 and BRCA2
DE Goldgar et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
分享论文
